Your browser doesn't support javascript.
loading
MiR-302 a/b/c suppresses tumor angiogenesis in hepatocellular carcinoma by targeting MACC1.
Cao, Y-P; Pan, M; Song, Y-L; Zhang, H-L; Sui, H-T; Shan, B-C; Piao, H-X.
Affiliation
  • Cao YP; Department of Internal Medicine, Yanbian University, Yanji, Jilin, China. wmeqol@163.com.
Eur Rev Med Pharmacol Sci ; 23(18): 7863-7873, 2019 Sep.
Article in En | MEDLINE | ID: mdl-31599411
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / MicroRNAs / Liver Neoplasms / Neovascularization, Pathologic Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: Eur Rev Med Pharmacol Sci Journal subject: FARMACOLOGIA / TOXICOLOGIA Year: 2019 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / MicroRNAs / Liver Neoplasms / Neovascularization, Pathologic Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: Eur Rev Med Pharmacol Sci Journal subject: FARMACOLOGIA / TOXICOLOGIA Year: 2019 Document type: Article Affiliation country: Country of publication: